miscsubjectsAI governance
Evidence review

PT-141 for Nerve Damage: Evidence-Graded Review

· · 3 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `pt-141-nerve-damage`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/pt-141-nerve-damage

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-nerve-damage/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-nerve-damage/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-nerve-damage/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-nerve-damage/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why PT-141 might help you

  1. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • PT-141 → sexual / CNS arousal

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 4
  • Claims tagged human evidence: 1
  • Claims tagged preclinical (animal/lab): 2
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 6

Quantified confidence (this ledger): 0.3 / 1.00 — low — animal and anecdote heavy

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Double-blind, placebo-controlled evaluation of the safety, pharmacokinetics and pharmacodynamics of PT-141 (source s15)

Phase 1/2 safety data for PT-141 in humans; no nerve endpoints.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

The potent melanocortin receptor agonist melanotan-II promotes peripheral nerve regeneration and has neuroprotective properties in the rat (source s35)

Key rat study on MT-II in nerve crush and toxic neuropathy models.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Accelerating sensory recovery after sciatic nerve crush: non-selective versus melanocortin MC4 receptor-selective peptides (source s36)

Follow-up rat study comparing selectivity.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Melanocortin Receptors, Melanotropic Peptides and Penile Erection (source s16)

Review of PT-141 mechanism via melanocortin receptors.

Evidence type: Published research.

What people say on Reddit

PT-141 vs Melanotan-2 — Reddit, r/BodyHackGuide (source s24)

Community mention of the 2003 rat study in context of related compound.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Nerve damage / repair · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedPT-141: Brain-Level Arousal · 17 humanPT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood… · 8 humanPT-141 for Chemotherapy Side Effects: Evidence on Sexual Arousal Pathw… · 3 humanPT-141 for Diabetic Neuropathy: Evidence-Graded Review · 3 human
Evidence · 6 sources · swipe →chain 091fe30de88b · verify chain · provenance
1 / 6
Evidence ledger 4 · tier-ranked · API
human
No human clinical trials test PT-141 for nerve damage or neuropathy.
sources: s15, s20
preclinical
In a 2003 rat sciatic nerve crush model, Melanotan-II (MT-II) at 20 μg/kg every 48 h improved sensory recovery and showed partial neuroprotection against cisplatin neuropathy.
sources: s35
mechanistic
PT-141 activates MC3R and MC4R centrally to influence sexual arousal pathways.
sources: s16
preclinicallow confidence
A 2004 rat study found only non-selective melanocortin agonists like MT-II accelerated sensory recovery after nerve crush, unlike selective MC4 agonists.
sources: s36
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 01:13
PT-141 for Nerve Damage: Evidence-Graded Review · 4 claims · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: PT 141 for Nerve Damage
Slug: pt-141-nerve-damage
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"pt-141","name":"PT-141"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenera
it output
{
  "slug": "pt-141-nerve-damage",
  "title": "PT-141 for Nerve Damage: Evidence-Graded Review",
  "body": "## What's breaking down\n\nNerve damage involves layers of degeneration. Axons can break or retract after injury or toxicity. Myelin sheaths around nerves can degrade, slowing signal conduction. Schwann cells and supporting glia may fail to remyelinate or guide regrowth. Sensory and motor endpoints lose function, leading to numbness, weakness, or pain. Central nervous system components tied to arousal pathways can also show disrupted signaling if peripheral input is lost. These layers create a net where breakdown outruns natural repair, leaving persistent deficits. PT-141 is discussed here in the context of its studied effects on melanocortin pathways in the CNS that influence arousal, not as a direct nerve regenerator.\n\n## Why PT-141 might help you\n\n1. If your nerve damage affects sexual function through reduced CNS arousal signaling, PT-141 is studied because it activates melanocortin receptors (MC3R and MC4R) in brain areas linked to motivation and desire. \n2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain. The compound engages central pathways that may support downstream tissue responses rather than blocking symptoms.\n3. If peripheral nerve issues have secondarily dampe
4ab860ae7e4cec33
Machine verification: /api/articles/pt-141-nerve-damage/contributions

Related articles

Nerve damage / repair · condition map

Open evidence map →
PT-141: Brain-Level Arousalpt-141PT-141 and Benzodiazepine Withdrawal: A Data-First Evidence Reviewpt-141-benzo-withdrawalPT-141 and Benzodiazepines: Evidence Review on CNS Arousal Layerspt-141-benzodiazepinesPT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood…pt-141-blood-pressure-medsPT-141 for Statin-Associated Cognitive Effects: Evidence Reviewpt-141-brain-fogPT-141 for Carpal Tunnel Syndrome: A Data-First Evidence Reviewpt-141-carpal-tunnel
Ask this article · 7 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "No human clinical trials test PT-141 for nerve damage or neuropathy."?
ask pt-141-nerve-damage claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "In a 2003 rat sciatic nerve crush model, Melanotan-II (MT-II) at 20 μg/kg every 48 h improved sensory recovery and showed partial neuroprote…"?
ask pt-141-nerve-damage claim c2 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "PT-141 activates MC3R and MC4R centrally to influence sexual arousal pathways."?
ask pt-141-nerve-damage claim c3 · paste includes §SELF
What does the ledger say about this (preclinical tier): "A 2004 rat study found only non-selective melanocortin agonists like MT-II accelerated sensory recovery after nerve crush, unlike selective …"?
ask pt-141-nerve-damage claim c4 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Community mention of the 2003 rat study in context of related compound."
ask pt-141-nerve-damage source s24 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about PT-141 for Nerve Damage: Evidence-Graded Review — and what would you need me to tell you first?
ask pt-141-nerve-damage condition gaps · paste includes §SELF
What good and bad outcomes are documented for PT-141 for Nerve Damage: Evidence-Graded Review (studies vs anecdotes)?
ask pt-141-nerve-damage good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…